← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:951 | 951 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:951 | 951 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:951 | 951 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-2552 | 73271-2552-1 | Lidocaine; Prilocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:951 | 951 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0416 | 72196-0416-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:951 | 951 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:951 | 951 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:951 | 951 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0407 | 71285-0407-1 | N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:951 | 951 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-979 | 69374-979-50 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:951 | 951 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8475 | 71266-8475-3 | Mitomycin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:951 | 951 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-05 | Midazolam | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:951 | 951 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5022 | 26436-5022-1 | Nandrolone Decanoate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:951 | 951 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-115 | 69194-115-10 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:951 | 951 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:951 | 951 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6042 | 71285-6042-1 | Oxytocin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:951 | 951 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-018 | 73198-018-10 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:952 | 952 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5233 | 26436-5233-6 | BUTT BALM | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:952 | 952 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:952 | 952 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Epinephrine Bitartrate | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:952 | 952 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-4552 | 73271-4552-1 | Lidocaine; Prilocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:952 | 952 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0415 | 71285-0415-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:952 | 952 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:952 | 952 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:952 | 952 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nadide | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:952 | 952 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-1 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:952 | 952 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8515 | 71266-8515-3 | Mitomycin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:952 | 952 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-01 | Midazolam | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:952 | 952 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:952 | 952 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-119 | 69194-119-10 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:952 | 952 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:952 | 952 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0903 | 83863-0903-1 | Oxytocin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:952 | 952 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-018 | 73198-018-03 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:953 | 953 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-1818 | 72907-1818-5 | Triamcinolone Acetonide | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:953 | 953 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:953 | 953 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Epinephrine Bitartrate | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:953 | 953 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-4114 | 73271-4114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:953 | 953 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0430 | 71285-0430-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:953 | 953 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:953 | 953 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine; Phenylephrine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:953 | 953 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5558 | 26436-5558-1 | Nadide | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:953 | 953 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-3 | Morphine Sulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:953 | 953 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6412 | 71266-6412-3 | Mitomycin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:953 | 953 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1337 | 61141-1337-1 | Midazolam | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:953 | 953 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:953 | 953 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-025 | 71506-025-58 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:953 | 953 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-117 | 69194-117-10 | Norepinephrine Bitartrate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:953 | 953 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5007 | 26436-5007-3 | Panthenol | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:953 | 953 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-020 | 73198-020-03 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:954 | 954 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-2 | Neostigmine Methylsulfate | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:954 | 954 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:954 | 954 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:954 | 954 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1552 | 73271-1552-1 | Lidocaine; Prilocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:954 | 954 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0422 | 71285-0422-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:954 | 954 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8088 | 71285-8088-1 | Lidocaine Hydrochloride Anhydrous | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:954 | 954 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine; Phenylephrine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:954 | 954 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0724 | 26436-0724-1 | Naltrexone | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:954 | 954 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate Anhydrous | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:954 | 954 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:954 | 954 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:954 | 954 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:954 | 954 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-032 | 71506-032-58 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:954 | 954 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-348 | 83298-348-09 | Norepinephrine Bitartrate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:954 | 954 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5097 | 26436-5097-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:954 | 954 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-020 | 73198-020-10 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:955 | 955 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9684 | 71266-9684-5 | Succinylcholine Chloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:955 | 955 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:955 | 955 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:955 | 955 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-8114 | 73271-8114-1 | Lidocaine; Prilocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:955 | 955 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0425 | 71285-0425-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:955 | 955 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8089 | 71285-8089-1 | Lidocaine Hydrochloride Anhydrous | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:955 | 955 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine; Prilocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:955 | 955 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:955 | 955 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate Anhydrous | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:955 | 955 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-613 | 70092-613-79 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:955 | 955 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:955 | 955 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-002 | 72055-002-01 | Neostigmine Methylsulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:955 | 955 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-348 | 83298-348-09 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:955 | 955 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-010 | 72055-010-01 | Norepinephrine Bitartrate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:955 | 955 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:955 | 955 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-019 | 73198-019-10 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:956 | 956 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-294 | 70092-294-74 | Hydromorph PF 1 mg/ml 50ml NS CADD FSFF | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:956 | 956 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-7 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:956 | 956 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine Hydrochloride; Prilocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:956 | 956 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-3552 | 73271-3552-1 | Lidocaine; Prilocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:956 | 956 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0408 | 71285-0408-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:956 | 956 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride Anhydrous; Epinephrine | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:956 | 956 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine; Prilocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:956 | 956 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:956 | 956 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate Anhydrous | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:956 | 956 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:956 | 956 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:956 | 956 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-15 | Neostigmine Methylsulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:956 | 956 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-010 | 72055-010-01 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:956 | 956 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-009 | 72055-009-01 | Norepinephrine Bitartrate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:956 | 956 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:956 | 956 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5580 | 26436-5580-1 | Phenol | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:957 | 957 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6422 | 72682-6422-1 | MIC with Cyanocobalamin 25/50/50/1mg per ml 30mL | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:957 | 957 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-996 | 69374-996-05 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:957 | 957 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine; Epinephrine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:957 | 957 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0863 | 5446-0863-01 | Lidocaine; Racepinephrine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:957 | 957 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0408 | 72196-0408-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:957 | 957 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 33216-785 | 33216-785-65 | Lidocaine Hydrochloride; Bupivacaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:957 | 957 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine; Prilocaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:957 | 957 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Naltrexone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:957 | 957 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate Anhydrous | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:957 | 957 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:957 | 957 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-401 | 73702-401-02 | Midazolam | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:957 | 957 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-53 | Neostigmine Methylsulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:957 | 957 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-017 | 72055-017-01 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:957 | 957 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:957 | 957 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5112 | 26436-5112-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:957 | 957 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6519 | 71266-6519-1 | Phenol | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:958 | 958 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73217-007 | 73217-007-10 | Tacrolimus 0.3% Ophth | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:958 | 958 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-3 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:958 | 958 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1235 | 5446-1235-01 | Lidocaine; Benzocaine; Tetracaine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:958 | 958 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1268 | 5446-1268-01 | Lidocaine; Racepinephrine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:958 | 958 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0406 | 72196-0406-1 | Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:958 | 958 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 33216-839 | 33216-839-05 | Lidocaine Hydrochloride; Ephedrine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:958 | 958 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Benzocaine; Tetracaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:958 | 958 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6220 | 72682-6220-1 | Nandrolone Decanoate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:958 | 958 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:958 | 958 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-521 | 70092-521-74 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:958 | 958 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-401 | 73702-401-01 | Midazolam | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:958 | 958 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-501 | 65302-501-03 | Neostigmine Methylsulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:958 | 958 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-009 | 72055-009-01 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:958 | 958 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:958 | 958 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5183 | 26436-5183-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:958 | 958 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-006 | 73198-006-03 | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:959 | 959 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-004 | 68985-004-94 | PHENYLEPHRINE 40MG | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:959 | 959 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:959 | 959 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3100 | 72627-3100-1 | Lidocaine; Benzocaine; Tetracaine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:959 | 959 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1276 | 5446-1276-01 | Lidocaine; Racepinephrine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:959 | 959 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0406 | 71285-0406-1 | Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:959 | 959 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6290 | 71266-6290-1 | Lidocaine Hydrochloride; Epinephrine Bitartrate; Tetracaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:959 | 959 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3100 | 72627-3100-1 | Lidocaine; Benzocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:959 | 959 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2107 | 72627-2107-3 | Nandrolone Decanoate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:959 | 959 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:959 | 959 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:959 | 959 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5020 | 70214-5020-1 | Midazolam | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:959 | 959 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-501 | 65302-501-05 | Neostigmine Methylsulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:959 | 959 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-931 | 68985-931-98 | Norepinephrine Bitartrate | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:959 | 959 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:959 | 959 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5137 | 26436-5137-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:959 | 959 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-006 | 73198-006-10 | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:960 | 960 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-366 | 73693-366-01 | TESTOSTERONE, TRIAMCINOLONE 62.5MG, 12.5MCG | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:960 | 960 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:960 | 960 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3101 | 72627-3101-1 | Lidocaine; Benzocaine; Tetracaine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:960 | 960 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0607 | 5446-0607-01 | Lidocaine; Racepinephrine; Tetracaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:960 | 960 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69324-050 | 69324-050-01 | Lysine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:960 | 960 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:960 | 960 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3101 | 72627-3101-1 | Lidocaine; Benzocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:960 | 960 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-103 | 71449-103-11 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:960 | 960 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-096 | 71449-096-42 | Moxifloxacin Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:960 | 960 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-132 | 70092-132-43 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:960 | 960 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-1 | Midazolam | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:960 | 960 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-125 | 71449-125-11 | Neostigmine Methylsulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:960 | 960 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:960 | 960 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-931 | 68985-931-98 | Norepinephrine Bitartrate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:960 | 960 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:960 | 960 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-011 | 73198-011-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:961 | 961 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9057 | 83826-9057-2 | Tropicamide, Phenylephrine HCl | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:961 | 961 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:961 | 961 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Dibucaine Hydrochloride; Phenylephrine Hydrochloride; Prilocaine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:961 | 961 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:961 | 961 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-988 | 69374-988-10 | Lysine Hydrochloride; Arginine Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:961 | 961 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:961 | 961 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1235 | 5446-1235-01 | Lidocaine; Benzocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:961 | 961 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-002 | 72055-002-01 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:961 | 961 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:961 | 961 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:961 | 961 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-6 | Midazolam | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:961 | 961 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:961 | 961 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:961 | 961 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:961 | 961 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:961 | 961 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-011 | 73198-011-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:962 | 962 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-1025 | 79559-1025-1 | S-T025 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:962 | 962 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-3 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:962 | 962 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Dibucaine Hydrochloride; Phenylephrine Hydrochloride; Prilocaine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:962 | 962 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3102 | 72627-3102-1 | Lidocaine; Tetracaine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:962 | 962 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine Hydrochloride; Arginine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:962 | 962 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:962 | 962 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 80098-008 | 80098-008-01 | Lidocaine; Epinephrine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:962 | 962 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-15 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:962 | 962 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8604 | 71266-8604-1 | Moxifloxacin Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:962 | 962 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-128 | 70092-128-50 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:962 | 962 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4036 | 71286-4036-1 | Midazolam Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:962 | 962 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-9 | Neostigmine Methylsulfate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:962 | 962 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:962 | 962 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-025 | 71506-025-58 | Norepinephrine Bitartrate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:962 | 962 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:962 | 962 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-014 | 73198-014-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:963 | 963 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-873 | 69761-873-01 | Testosterone | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:963 | 963 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-5 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:963 | 963 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1543 | 5446-1543-01 | Lidocaine; Hyaluronidase; Bupivacaine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:963 | 963 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine; Benzocaine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:963 | 963 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5105 | 26436-5105-5 | Magnesium Chloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:963 | 963 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:963 | 963 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1548 | 5446-1548-01 | Lidocaine; Hyaluronidase; Bupivacaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:963 | 963 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-53 | Neostigmine Methylsulfate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:963 | 963 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8613 | 71266-8613-1 | Moxifloxacin Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 |